• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Kojima Yuki  小島 勇貴

ORCIDConnect your ORCID iD *help
Researcher Number 40577904
Other IDs
Affiliation (Current) 2025: 国立研究開発法人国立がん研究センター, 中央病院, 医員
Affiliation (based on the past Project Information) *help 2021 – 2023: 国立研究開発法人国立がん研究センター, 中央病院, 医員
2020: 国立研究開発法人国立がん研究センター, 中央病院, がん専門修練医
Review Section/Research Field
Principal Investigator
Basic Section 50020:Tumor diagnostics and therapeutics-related
Keywords
Principal Investigator
ドラッグ・リポジショニング / バイオマーカー / ドラッグリポジショニング / PDX / 希少がん
  • Research Projects

    (1 results)
  • Research Products

    (5 results)
  • Co-Researchers

    (1 People)
  •  Patient-derived xenograft models for rare cancer drug developmentPrincipal Investigator

    • Principal Investigator
      Kojima Yuki
    • Project Period (FY)
      2020 – 2023
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      National Cancer Center Japan

All 2023 2021

All Journal Article Presentation

  • [Journal Article] Therapeutic target biomarkers of patient-derived xenograft models of gastric-type cervical adenocarcinoma2023

    • Author(s)
      Kojima Yuki、Yoshida Hiroshi、Okuya Toshihiro、Okuma Hitomi S、Nishikawa Tadaaki、Tanioka Maki、Sudo Kazuki、Noguchi Emi、Shimoi Tatsunori、Tamura Kenji、Tanase Yasuhito、Uno Masaya、Ishikawa Mitsuya、Arakaki Motoko、Ichikawa Hitoshi、Yagishita Shigehiro、Hamada Akinobu、Fujiwara Yasuhiro、Yonemori Kan、Kato Tomoyasu
    • Journal Title

      Gynecologic Oncology Reports

      Volume: 50 Pages: 101302-101302

    • DOI

      10.1016/j.gore.2023.101302

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-22K09563, KAKENHI-PROJECT-20K16430
  • [Presentation] Trastuzumab deruxtecan, antibody-drug conjugate targeting HER2, effectively inhibits growth of patient-derived xenograft model with CIC-rearranged sarcoma2023

    • Author(s)
      Yuki Kojima; Shigehiro Yagishita; Kazuki Sudo; Tatsunori Shimoi; Shintaro Iwata; Shun-ichi Watanabe; Chitose Ogawa; Akihiko Yoshida; Yasushi Yatabe; Kan Yonemori; Akinobu Hamada
    • Organizer
      American Association for Cancer Research Annual Meeting 2023
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20K16430
  • [Presentation] Trastuzumab deruxtecan, antibody-drug conjugate targeting HER2, effectively inhibits growth of patient-derived xenograft model with CIC-rearranged Sarcoma2023

    • Author(s)
      Yuki Kojima
    • Organizer
      、American Association for Cancer Research annual meeting 2023
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20K16430
  • [Presentation] Characterization based on therapeutic target biomarkers of patients-driven xenografts model of gastric-type cervical adenocarcinoma2021

    • Author(s)
      uki Kojima, Hiroshi Yoshida, Toshihiro Okuya, Hitomi S Okuma, Tadaaki Nishikawa, Maki Tanioka, Kazuki Sudo, Emi Noguchi, Tatsunori Shimoi, Yasuhito Tanase, Masaya Uno, Mitsuya Ishikawa, Yasuhiro Fujiwara, Kan Yonemori, Tomoyasu Kato
    • Organizer
      American Association for Cancer Research
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20K16430
  • [Presentation] Characterization based on therapeutic target biomarkers of patients-driven xenografts model of gastric-type cervical adenocarcinoma2021

    • Author(s)
      Yuki Kojima
    • Organizer
      AACR annual meeting 2021
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-20K16430
  • 1.  加藤 友康
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi